Inactive Instrument

THIE POIN Stock

THMA

US88408P1075

Thimble Point Acquisition Corp. is a blank check company. The Company created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses on software and technology-enabled sectors. The Company has no operations and has not generated revenues.

Employees

Sector

More about the company

21-12-03	Thimble Point Acquisition, Pear Therapeutics Close SPAC Merger; Combined Firm to Begin Trading Monday	MT
21-12-03	Thimble Point Acquisition Corp.(NasdaqCM:THMA) dropped from NASDAQ Composite Index	CI
21-12-02	Pear Therapeutics, Inc. completed the acquisition of Thimble Point Acquisition Corp. from LJ10 LLC and others in a reverse merger transaction.	CI
21-11-22	Pear Therapeutics Receives FDA Breakthrough Designation for reSET-A	DJ
21-11-05	Thimble Point Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-08-01	Certain Class B Common Stock of Thimble Point Acquisition Corp. are subject to a Lock-Up Agreement Ending on 2-AUG-2021.	CI
21-06-22	Thimble Point Acquisition : Pear Therapeutics to Merge With Thimble Point Acquisition to Go Public, Strengthen Position in Prescription Digital Therapeutics	MT
21-06-22	Thimble Point Acquisition : Pear Therapeutics to Go Public by Combining with Blank-Check Firm Thimble Point Acquisition in $1.6 Billion Deal	MT
21-06-22	SoftBank : backed Pear Therapeutics agrees $1.6 billion SPAC deal	RE
21-06-22	SOFTBANK-BACKED HEALTHCARE STARTUP PEAR THERAPEUTICS TO LIST THROUGH $1.6 BLN MERGER WITH BLANK CHEQUE COMPANY THIMBLe point ACQUISITION CORP	RE
21-06-21	Pear Therapeutics, Inc. entered into a definitive business combination agreement to acquire Thimble Point Acquisition Corp. from LJ10 LLC and others in a reverse merger transaction.	CI
21-03-30	Thimble Point Acquisition Corp.(NasdaqCM:THMA) added to NASDAQ Composite Index	CI
21-02-04	Thimble Point Acquisition Corp. Announces Board Appointments	CI

21-12-08	Thimble Point Acquisition : INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K	PU
21-12-03	Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company	BU
21-11-30	THIMBLE POINT ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
21-11-23	THIMBLE POINT ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	AQ
21-11-23	Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference	BU

Date	Insider	Type	Main position	Quantity	% Market Cap.
12/3/21	LJ10 LLC	Conversion	Company	6,540,000	21.8000%
2/1/21	Meghan Fitzgerald	Other	Director	50,000	0.1667%
2/1/21	Michael Christenson	Other	Director	50,000	0.1667%

THIE POIN Stock

Stocks

THMA

US88408P1075

Latest news : THIE POIN

Press Releases : THIE POIN

Quotes and Performance

Latest insider transactions

Company Profile